Skip to main content
Log in

Validation of a point of care lipid analyser using a hospital based reference laboratory

  • Original Paper
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Lipid measurements are essential in cardiovascular disease management in primary care. However, utilizing hospital laboratories may result in excess patient travel, sample loss and repeat clinic visits. Point of care (POC) lipid measurement would overcome these difficulties but has not been validated in an Irish setting.

Aim

To compare POC lipid profile measurements using a cholestech LDX analyser with a hospital reference laboratory (Lab).

Method

One-hundred subjects (30 men, 70 women) participated. Finger prick and venous samples were analysed directly by Cholestech LDX and the Lab.

Results

A broad range of lipid values were measured. Absolute differences between POC and Lab measurements were insignificant except for a small over-estimation by the POC method of triglyceride 0.25mmol/l (95% CI 0.17 to 0.24), and an underestimation of HDLc — 0.11mmol/l (95% CI −0.143 to −0.078). There were significant correlations between POC and Lab. levels; total cholesterol r=0.92, triglyceride r=0.93, HDLc r=0.92 and LDLc r=0.86 (all p< 0.0001).

Conclusion

These results validate the use of the Cholestech LDX® analyser for point of care lipid measurements in clinical practice, provided well trained operators are supported by a hospital laboratory delivering quality assurance support.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. 50 years of Heart Disease in Ireland. Mortality, morbidity and health services implications. Dublin: Irish Heart Foundation, 2001.

  2. Heartwatch.The national programme in general practice for the secondary prevention of cardiovascular disease in Ireland. Annual Report 2004 –2005 ICGP

  3. Point of Care Diagnostic testing — world markets report Guinness Centre, Taylor’s Lane, Dublin 8

  4. CH Sloop, L Dory, PS Roheim. Interstitial fluid lipoproteinsJ Lipid Res, 1987; Vol 28, 225–237.

    CAS  PubMed  Google Scholar 

  5. Cummings MH, Watts GF, Mazurkiewicz JC, Slavin BM. An evaluation in the diabetes clinic of the Cholestech L-D-X analyser. Practical Diabetes July/August 1994; 11(4):151–153.

    Article  Google Scholar 

  6. Friedewald, WT, et al., Estimation of the Concentrations of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge,Clin. Chem., 1972; 18/6:499.

    CAS  PubMed  Google Scholar 

  7. UK Joint Working Group on Quality Assurance. Near to Patient or Point of Care Testing Guidelines. Association of Clinical Biochemists, Institute of Biomedical Sciences, Royal College of Pathologists January 1999

  8. Policy Guidelines on Near Patient Testing. Academy of Medical Laboratory Science 1998

  9. Additional essential criteria for quality systems of medical laboratories. Jansen R.T.P., Blaton V., Burnett D., Huisman W., Queralto J.M., Zerah S. Allman B.Clin. Chem Lab. Med. 1998; 36 (4):249–252.

    Article  CAS  PubMed  Google Scholar 

  10. European guidelines on Cardiovascular disease prevention in clinical practice.Eur Heart J 2003; 24, 1601–1610.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Maher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carey, M., Markham, C., Gaffney, P. et al. Validation of a point of care lipid analyser using a hospital based reference laboratory. Ir J Med Sci 175, 30–35 (2006). https://doi.org/10.1007/BF03167964

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03167964

Keywords

Navigation